Good oils now in health guidelines

Monday, 08 May, 2006

The health benefits associated with consuming Omega-3 oils have been highlighted in a new Federal Government guide to the nutritional values of foods.

Nutritional authorities suggest a dietary target of at least 430 mg for women and 610 mg for men of long-chain Omega-3, including EPA (eicosapentaenoic acid) and DHA (docosa-hexaenoic acid), to reduce the risk of chronic disease. Dietary surveys show that most Australians consume a fraction of this amount.

The health benefits of Omega-3 oils have been known for many years.

"It is 30 years since the original observation that diets high in long-chain Omega-3 oils may be associated with cardiovascular health benefits," Dr Mahinda Abeywardena, principal scientist with the Food Futures Flagship said.

"In addition to a wealth of supporting evidence for this claim, current knowledge also assigns several other benefits of Omega-3 oils including foetal and early childhood growth and development, anti-inflammatory as well as possible benefits on neuropsychiatric disorders " cognition, Alzheimer's disease, mood and depression."

Making these valuable oils more readily available to the community is a major research project for the Flagship. In a world first, the Flagship recently developed land-based plants that produce DHA " a healthy Omega-3 oil component normally only available from fish sources.

"The Food Futures Flagship is committed on a number of research fronts to developing new and sustainable sources of Omega-3 oils," Dr Bruce Lee, Director of Food Futures Flagship says.

"Showing that plants can produce DHA in their seeds is a major scientific accomplishment. It is an important first step towards improving human nutrition and reducing pressure on declining fish resources worldwide."

Related News

A pinch of saltbush for functional and nutritional benefits

An Australian desert plant could help food manufacturers improve protein quality and reduce...

Chemical food additive BHA under review in the US

The FDA identified butylated hydroxyanisole (BHA) as a top priority for review as part of its...

Call for comment on a new source of 2′-FL in infant formula products

FSANZ is calling for comments on an application to permit 2′-fucosyllactose produced from a...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd